Advertisement
Advertisement
ICCC
Immucell Corp
10.26
USDSponsored
+0.04
+0.39%
Nov 10, 15:54 UTC -5
Closed
After-Market
10.31
+0.05
+0.54%
Immucell Corp (ICCC) Earnings
ICCC Earnings Reports
Positive Surprise Ratio
ICCC beat 2 of 3 last estimates.
67%
Next Report
In 2 Days
Date of Next Report
Nov 12, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/--
Implied change from Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q3 25 (Revenue/ EPS)
--
/--
Immucell Corp earnings per share and revenue
On Aug 13, 2026, ICCC reported earnings of 0.20 USD per share (EPS) for Q2 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached 7.19 million, compared to an expected --, with a --% difference. The market reacted with a -7.80% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Lumexa Imaging Holdings, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
$0.18
Actual
$0.26
Surprise
+39.63%
Capricor Therapeutics Inc
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.44
Actual
-$0.73
Surprise
-65.16%
Village Farms International, Inc. Common Shares
Report Date
Nov 09, 2026 For Q3 26
Estimate
$0.05
Actual
$0.08
Surprise
+48.42%
Canopy Growth Corporation Common Shares
Report Date
Nov 06, 2026 For Q2 27
Estimate
-$0.03
Actual
-$0.01
Surprise
+71.75%
OraSure Technologies Inc
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.20
Actual
-$0.15
Surprise
+28.26%
TriSalus Life Sciences, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.15
Surprise
-14.85%
Exagen Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.18
Actual
-$0.25
Surprise
-35.35%
Quanterix Corporation Common Stock
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.44
Actual
-$0.46
Surprise
-3.67%
Prestige Consumer Healthcare Inc.
Report Date
Nov 05, 2026 For Q2 27
Estimate
$1.08
Actual
$1.12
Surprise
+4.28%
Myomo Inc.
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.07
Actual
-$0.07
Surprise
+11.17%
FAQ
What were Immucell Corp's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Immucell Corp reported EPS of $0.20, missing estimates by --, and revenue of $7.19M, -- -- expectations.
How did the market react to Immucell Corp's Q2 2026 earnings?
The stock price moved down -7.8%, changed from $10.90 before the earnings release to $10.05 the day after.
When is Immucell Corp expected to report next?
The next earning report is scheduled for Nov 12, 2026.
What are the forecasts for Immucell Corp's next earnings report?
Based on --
analysts, Immucell Corp is expected to report EPS of -- and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.